Results 171 to 180 of about 200,281 (336)
A Proteomic Atlas of Renal Amyloidosis Provides Insights Into Disease Pathogenesis
Taxiarchis Kourelis
openalex +2 more sources
Microvascular obstruction in cardiac amyloidosis
European Journal of Heart Failure, EarlyView.
Lucrezia Netti +19 more
wiley +1 more source
Pathophysiologic mechanisms of heart failure (HF) (i.e. renin–angiotensin–aldosterone system [RAAS], congestion, and inflammation), together with patient‐related factors such as diabetes, hypertension, and chronic kidney disease (CKD), contribute to kidney function decline and glomerular or tubular injury.
Masatake Kobayashi +14 more
wiley +1 more source
Renal Response Criteria for Clinical Trials in Amyloid Light Chain Amyloidosis
Immunoglobin light chain (AL) amyloidosis is a rare disease characterized by organ deposition of amyloid fibrils, most commonly in the heart and kidney.
Nelson Leung +11 more
doaj +1 more source
AA amyloidosis in a patient with Langerhans cell histiocytosis [PDF]
Peter C. Thomson +4 more
openalex +1 more source
Generalized lichen amyloidosis in a pregnant woman: Coincidence or association
Phyo Zaw Aung, Thamthiwat Nararatwanchai
openalex +2 more sources
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
J. Gillmore +31 more
semanticscholar +1 more source
Summary of the HELIOS‐B trial design. Right: Forest (top) and spline (bottom) plots demonstrating the effect of vutrisiran versus placebo on clinical outcomes across age groups in HELIOS‐B. Age‐stratified outcomes with vutrisiran in transthyretin amyloid cardiomyopathy.
Awais Sheikh +8 more
wiley +1 more source
The 2/20/20 International Myeloma Working Group (IMWG) score is the most employed risk score in clinical practice to evaluate the risk of progression from smoldering multiple myeloma (SMM) to symptomatic multiple myeloma.
Anna deDaniel +10 more
doaj +1 more source

